Review Criteria for Assessment of C-Reactive Protein (CRP), High Sensitivity C-Reactive Protein (hsCRP) and Cardiac C-Reactive Assays: Guidance for Industry and FDA Staff

Information

Type

Guidance

Regulated products

Medical Devices

Topics

Postmarket

Published

September 22, 2005

Last updated

March 19, 2020

Description

This document is a guidance for industry and FDA staff on the review criteria for assessing CRP, hsCRP, and cardiac CRP assays.

Organization

Country / Region

United States

License

Other (Public Domain)

Feedback

Suggest an improvement to this page

Actions

Social networks

Embed